Comparison of monthly minodronate versus weekly bisphosphonate on bone mineral density in women with postmenopausal osteoporosis
Latest Information Update: 30 Nov 2016
At a glance
- Drugs Minodronic acid (Primary) ; Alendronic acid; Risedronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 29 Nov 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 01 Jun 2012 New trial record